Twisted Fallopian Tubes

NCT ID: NCT04813367

Last Updated: 2021-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-30

Study Completion Date

2021-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Isolated tubal torsion is a very rare event already in adults (1: 1.5 million women), it remains exceptional in children without being able to find a prevalence in the literature. The causes can be malformative or idiopathic, but even that remains unknown.

Because of the scarcity, surgical treatment is not standardized and left to the good care of the surgeon in charge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Twisted Fallopian Tube

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Twisted fallopian tubes cohort

Description of girls who went through surgery for twisted fallopian tubes

Surgery of twisted fallopian tubes

Intervention Type PROCEDURE

Patients diagnosed with twisted fallopian tube go through surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery of twisted fallopian tubes

Patients diagnosed with twisted fallopian tube go through surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient younger then 18 going through surgery for twisted fallopian tubes

Exclusion Criteria

* Girl above 18 and tubal torsion associated with ovary torsion
Maximum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens

Amiens, , France

Site Status

Centre Hospitalier Universitaire de Angers

Angers, , France

Site Status

APHM, Hôpital La Timone Enfants et Hôpital Nord

Marseille, , France

Site Status

Hopital NECKER Enfant Malades

Paris, , France

Site Status

ASP Trapani - presidio ospedaliero "S. Antonio Abate

Erice, , Italy

Site Status

Azienda Ospedaliera Universitaria di Padova

Padua, , Italy

Site Status

AOU Siena, Ospedale le Scotte

Siena, , Italy

Site Status

Ospedale infantile Regina Margherita

Torino, , Italy

Site Status

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo

Trieste, , Italy

Site Status

Institute for Maternal and Child Health IRCCS G. Gaslini, Genova

Trieste, , Italy

Site Status

Hôtel-Dieu de France Hospital

Beirut, , Lebanon

Site Status

Hospital d Urgences pour les enfants

Iași, , Romania

Site Status

Ege University Faculty of Medicine Children's Hospital

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Italy Lebanon Romania Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel GORDUZA, Dr

Role: CONTACT

4 72 35 52 27 ext. +33

Julien BERTHILLER, Dr

Role: CONTACT

4 27 85 63 01 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL21_0239

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.